EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Prevention of Cardiovascular Disease and Cancer Through Early Statin Treatment in Advanced Atherosclerosis: An Observational Study

Ansgar Adams, Waldemar Bojara, Michel Romanens

Cardiology Research · 2026-04 · 17 (2) · 120-127

DOI: 10.14740/cr2196 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cardiology Research, 2026-04. Verfasst von Ansgar Adams und 2 weiteren Autor:innen. Beteiligte Einrichtung: BG Prevent GmbH Zentrum Koblenz, Koblenz, Germany. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The extent of atherosclerosis in healthy men and women was measured using ultrasound on the carotid artery, and it was investigated whether early treatment with statins in subjects with advanced atherosclerosis improves the outcome for cardiovascular disease and cancer.

Method

From 2009 to 2017, 5,186 subjects (39.1% women) aged 35–65 with no signs of cardiovascular disease underwent ultrasound examination of the carotid artery. The total plaque area (TPA) and maximum plaque thickness were measured.

Results

A follow-up was available for 4,340 (83.7%) participants. The mean follow-up period was 87 months (7.3 years) for men and 79 months (6.6 years) for women. Advanced atherosclerosis (type III, IVb) was present in 506 (11.7%) subjects. Statin treatment was initiated in 186 (36.8%) of the subjects. Events (heart attack, ischemic stroke, coronary artery bypass grafting (CABG), percutaneous transluminal coronary angioplasty (PTCA)) occurred in 170 (3.9%) of the 4,340 subjects with follow-up data. Cancer occurred in 71 (1.7%) of the subjects. The event rate for cardiovascular events was 37.6% in men with advanced atherosclerosis without statin therapy vs. 1.6% (P < 0.0001) in those with low-to-moderate plaque burden; for cancer, the rates were 8.6% vs. 1.2% (P < 0.0001). In women with advanced atherosclerosis, the event rate for cardiovascular events without statin therapy was 14.8% vs. 0.2% (P < 0.0001) in those with low-to-moderate plaque burden; and for cancer, the rates were 7.4% vs. 0.9% (P = 0.002). Treatment of male subjects with advanced atherosclerosis (type III, IVb) with a statin significantly improved the prognosis. The event rate for cardiovascular events was 16.1% in men in the treated group vs. 37.6% (P < 0.0001) in the untreated group, and 2.7% vs. 14.8% (P = 0.077) in women. The event rate for cancer was 2% in men in the treated group vs. 8.6% (P = 0.006) in the untreated group. Due to the low number of cases in women, a statistical evaluation did not make sense. Mortality (from any cause) was significantly lower in men treated with statins (P = 0.008).

Conclusions

Treatment with statins in subjects with advanced atherosclerosis of the carotid artery (type III, IVb findings on ultrasound) significantly improved the prognosis in a non-randomized observational study.

Schlagwörter

Stichwörter der Autor:innen

AtherosclerosisCancerCardiovascular riskCarotid ultrasoundMicrovascular dysfunction

Autor:innen und Institutionen

  • BG Prevent GmbH Zentrum Koblenz, Koblenz, Germany.
  • Medizinische Klinik I Kardiologie Osnabruck, Klinikum Osnabruck, Germany.
  • Vascular Risk Foundation (Varifo), Olten, Switzerland.

Zitieren

APA

Adams, A., Bojara, W., & Romanens, M. (2026). Prevention of Cardiovascular Disease and Cancer Through Early Statin Treatment in Advanced Atherosclerosis: An Observational Study. Cardiology Research, 17(2), 120-127. https://doi.org/10.14740/cr2196

Vancouver

Adams A, Bojara W, Romanens M. Prevention of Cardiovascular Disease and Cancer Through Early Statin Treatment in Advanced Atherosclerosis: An Observational Study. Cardiology Research. 2026;17(2):120-127. doi:10.14740/cr2196

BibTeX
@article{Adams2026,
  author = {Adams, Ansgar and Bojara, Waldemar and Romanens, Michel},
  title = {Prevention of Cardiovascular Disease and Cancer Through Early Statin Treatment in Advanced Atherosclerosis: An Observational Study},
  journal = {Cardiology Research},
  year = {2026},
  volume = {17},
  number = {2},
  pages = {120--127},
  doi = {10.14740/cr2196}
}
Kostenlos starten →